Motilal Oswal Alternates has announced a $72 million minority investment in Sensa Core, an innovation-led medical devices company focused on advancing healthcare technology in India.
Founded in Hyderabad in 2006, Sensa Core designs, develops, manufactures and distributes specialised in-vitro diagnostic (IVD) devices with a strong IP-driven approach. What began as a fully bootstrapped venture has grown into a market leader in Electrolyte Analysers, with its solutions deployed across more than 40,000 hospitals and diagnostic laboratories in India, and exported to over 78 countries worldwide.
The company is also a leading domestic player in glucometers and haemoglobin meters, and has recently expanded its portfolio with a foray into arterial blood gas analysers. Sensa Core currently operates a dedicated manufacturing facility at the Export Promotion Industrial Park in Pashamylaram, Hyderabad, and is set to commission a new plant at the Medical Device Park in Sultanpur, Hyderabad, to enhance manufacturing capacity and support the development of new products.
